CFDE Data Portal | Search ACTG1P24

	Label	Description
	ACTG1P24 Gene (Entity type)	ENSG00000226359 - actin gamma 1 pseudogene 24
	GSE114883 romidepsin T cell 0 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE116133 GSE116136 H-7 1 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE128076 doxycycline HEK293 2 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE77108 saha 3 v 7 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE111247 temozolomide LN-308 2 v 4 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE183741 GSE183806 POU2F2 POU2AF1 knockdown UtE-iPS-1 2 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GTEx Breast 20-29 vs 40-49 Down Gene Set (Entity type)	A Gene Set from GTEx
	GTEx Liver 20-29 vs 40-49 Down Gene Set (Entity type)	A Gene Set from GTEx
	GTEx AdrenalGland 20-29 vs 60-69 Down Gene Set (Entity type)	A Gene Set from GTEx

ACTG1P24

ENSG00000226359 - actin gamma 1 pseudogene 24

GSE114883 romidepsin T cell 0 v 2 human up

A Gene Set from LINCS

GSE116133 GSE116136 H-7 1 v 0 human dn

A Gene Set from LINCS

GSE128076 doxycycline HEK293 2 v 0 human up

A Gene Set from LINCS

GSE77108 saha 3 v 7 human up

A Gene Set from LINCS

GSE111247 temozolomide LN-308 2 v 4 human up

A Gene Set from LINCS

GSE183741 GSE183806 POU2F2 POU2AF1 knockdown UtE-iPS-1 2 v 0 human up

A Gene Set from LINCS

GTEx Breast 20-29 vs 40-49 Down

A Gene Set from GTEx

GTEx Liver 20-29 vs 40-49 Down

A Gene Set from GTEx

GTEx AdrenalGland 20-29 vs 60-69 Down

A Gene Set from GTEx

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.